Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis we've ingested from peptide.partners, what each tests for, and what's missing. Sourced back to the original COA URLs — no hosting, no editorial.
Each row is one peptide. Columns show whether at least one COA from this vendor for that peptide tests for that property. Endotoxin and sterility are usually the gap.
| Peptide | COAs | Avg purity | HPLC | MS/MALDI | NMR | Endotoxin | Sterility | Metals | Microbial |
|---|---|---|---|---|---|---|---|---|---|
| 5-Amino-1MQ | 1 | 99.78% |
Most recent batches we've ingested. Each row links to the original COA file as published by the vendor.
How this is built: we discover every COA URL on the vendor's public testing page, fetch the file, run structured extraction, and persist what each COA actually tests for. Vendor copy isn't a signal — only the COAs themselves.
Full methodology →| — |
| AOD-9604 | 1 | — | — | — | — |
| BAC Water 0.9% | 1 | — | — | — | — | — | — |
| BPC-157 | 4 | 99.79% | — | — | — |
| BPC-157/TB-500 | 5 | 99.66% | — | — |
| Buffered NAD+ | 1 | — | — | — | — | — | — |
| Cagrilintide | 3 | 99.66% | — | — |
| CJC-1295 | 1 | 99.56% | — | — | — |
| DSIP | 2 | 99.85% | — | — |
| Epithalon | 1 | 99.86% | — | — |
| GHK-Cu | 4 | 99.82% | — | — |
| Glow | 1 | — | — | — | — |
| Humanin | 1 | 99.92% | — | — | — |
| Ipamorelin | 3 | 99.81% | — | — | — |
| Ipamorelin/CJC-1295 (no DAC) | 4 | 99.88% | — | — | — |
| KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV) | 2 | 99.86% | — | — |
| KPV | 2 | 99.91% | — | — | — | — |
| Meta-Z | 1 | — | — | — | — | — | — |
| MOTS-C | 5 | 99.82% | — | — |
| NAD+ | 4 | 99.81% | — | — |
| Pinealon | 1 | 99.97% | — | — |
| PT-141 | 1 | 99.89% | — | — | — |
| Retatrutide | 13 | 99.54% | — | — | — |
| Selank | 1 | 99.94% | — | — | — | — |
| Semaglutide | 3 | 99.54% | — | — | — |
| Semax | 1 | 99.92% | — | — |
| Semorelin | 1 | — | — | — | — | — |
| Sermorelin | 2 | 99.89% | — | — |
| SS-31 | 4 | 99.73% | — | — |
| TB-500 | 4 | 99.77% | — | — | — |
| Tesamorelin | 6 | 99.64% | — | — |
| Thymosin alpha-1 | 1 | 99.95% | — | — |
| Tirzepatide | 4 | 99.66% | — | — | — |
| VIP | 2 | 99.42% | — | — | — |
| — |
| View |
| Semaglutide | SM202512 | TrustPointe Analytics | — | LAL | — | View |
| 5-Amino-1MQ | AM202604 | Kovera Labs | 99.78% | MSLALUSP<71>HM | — | View |
| BPC-157/TB-500 | BB20251011 | TrustPointe Analytics | — | HM | — | View |
| Ipamorelin/CJC-1295 (no DAC) | CJIP202602 | TrustPointe Analytics | 99.94% | LALHM | — | View |
| Ipamorelin/CJC-1295 | CI20250805 | TrustPointe Analytics | 99.84% | LAL | — | View |
| Ipamorelin | IP20250721 | TrustPointe Analytics | 99.66% | LALHM | — | View |
| Tirzepatide | TZX202510 | TrustPointe Analytics | — | HM | — | View |
| Ipamorelin | IP202601 | TrustPointe Analytics | 99.95% | LALHM | — | View |
| Retatrutide | RP260130 | TrustPointe Analytics | 99.66% | LAL | — | View |
| Tesamorelin | TES202605 | TrustPointe Analytics | — | LALHM | — | View |
| Cagrilintide | CG202607 | TrustPointe Analytics | 99.73% | LALUSP<71>HM | — | View |
| Epithalon | ET202604 | Kovera Labs | 99.86% | MSLALUSP<71>HM | — | View |
| Pinealon | PN202603 | Kovera Labs | 99.97% | MSLALHM | — | View |
| BPC-157 / TB-500 | BB202604 | TrustPointe Analytics | 99.56% | LALHM | — | View |
| Cagrilintide | CAG202601 | TrustPointe Analytics | 99.34% | LALHM | — | View |
| Tesamorelin | TS20250722 | TrustPointe Analytics | 99.30% | LALHM | — | View |
| BAC Water 0.9% | BAC202603 | TrustPointe Analytics | — | LAL | — | View |
| TB-500 | TB20251012 | TrustPointe Analytics | — | HM | — | View |
| BPC-157 | BP202512 | TrustPointe Analytics | 99.47% | LALHM | — | View |
| BPC-157 | BP20250808 | TrustPointe Analytics | 100.00% | LALHM | — | View |
| NAD+ | NDB202606 | TrustPointe Analytics | — | LALHM | — | View |
| GHK-Cu | CU202605 | TrustPointe Analytics | — | LALUSP<71>HM | — | View |
| BPC-157/TB-500 | BB202605 | Kovera Labs | 99.90% | MSLALUSP<71>HM | — | View |
| AOD-9604 | AO202605 | TrustPointe Analytics | — | MSLALUSP<71>HM | — | View |
| Glow | GW202603 | TrustPointe Analytics | — | MSLALHM | — | View |
| SS-31 | SS202602 | TrustPointe Analytics | — | LALHM | — | View |
| Retatrutide | RP20251020 | TrustPointe Analytics | 99.33% | LAL | — | View |
| KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV) | KW202602 | TrustPointe Analytics | — | LALHM | — | View |
| Retatrutide | RP202511 | TrustPointe Analytics | 99.76% | LAL | — | View |
| GHK-Cu | CU202604 | Kovera Labs | 99.94% | MSLALUSP<71> | — | View |
| Semaglutide | SM20250801 | TrustPointe Analytics | 99.34% | LAL | — | View |
| MOTS-c | MC202603 | Kovera Labs | 99.96% | MSLALUSP<71>HM | — | View |
| TB-500 | TB20250614 | TrustPointe Analytics | 99.68% | LAL | — | View |
| Tesamorelin | TES202604 | Kovera Labs | 99.85% | MSLALUSP<71>HM | — | View |
| Retatrutide | RT202605 | TrustPointe Analytics | 99.72% | LAL | — | View |
| Retatrutide | RT202602 | TrustPointe Analytics | 99.67% | LALHM | — | View |
| BPC-157/TB-500 | BB202512 | TrustPointe Analytics | 99.64% | LALHM | — | View |
| Ipamorelin/CJC-1295 (No DAC) | CJIP202512 | TrustPointe Analytics | 99.82% | LAL | — | View |
| BPC-157 / TB-500 Blend | BB20250630 | TrustPointe Analytics | 99.52% | LAL | — | View |
| Sermorelin | SER202601 | Kovera Labs | 99.94% | MSLALHM | — | View |
| SS-31 | SS202601 | TrustPointe Analytics | 99.83% | LALUSP<71>HM | — | View |
| Tirzepatide | TZ20250730 | TrustPointe Analytics | 99.41% | LAL | — | View |
| DSIP | DS202605 | Kovera Labs | 99.81% | MSLALUSP<71>HM | — | View |
| SS-31 | SS202512 | TrustPointe Analytics | 99.67% | LAL | — | View |
| Retatrutide | Batch CD20250708 | TrustPointe Analytics | 99.42% | — | — | View |
| Retatrutide | RT202603 | TrustPointe Analytics | 99.50% | LALHM | — | View |
| Tirzepatide | TZ202603 | TrustPointe Analytics | 99.87% | LALHM | — | View |
Disclosed Labs